Michael Schweizer, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Sanofi
    Topic:
    Prostate cancer
    Date added:
    02/08/2023
    Date updated:
    05/20/2024
    Relationship end date:
    02/16/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    AstraZeneca
    Topic:
    Prostate cancer
    Date added:
    02/08/2023
    Date updated:
    05/20/2024
    Relationship end date:
    08/11/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pharmain
    Topic:
    Prostate cancer
    Date added:
    02/08/2023
    Date updated:
    05/20/2024
    Relationship end date:
    03/01/2022
Return to 2023 Summit on Cancer Health Disparities: Reframing and Addressing Barriers to Adoption of Precision Oncology